Komori
Zeria Pharmaceutical (4559) · PolicyRestated

Policy of contributing to improved quality of life as a comprehensive healthcare company

First written in FY2017. 3 of 4 entries say "Restated". Latest entry: FY2023.

4entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20232017: 120172018: 020182019: 120192020: 120202021: 020212022: 020222023: 12023
Same theme, other companies
Contributing to Healthcare and Public Health through Innovative Pharmaceuticals and ServicesA theme 14 companies write about · 0 as a headwind · 14 as a tailwind

The whole theme swung hardest in 2025: 1 of 7 companies on the "Worse" side.

10 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2023RestatedAnnual report

    「Based on the principle that “building health builds happiness,” our group, as an integrated healthcare company, engages in the research and development, manufacture, and sale of pharmaceuticals that address international medical needs and consumer healthcare products focused on self-medication, in order to contribute to improving quality of life.」

    The company continues to pursue its basic policy of contributing to improved quality of life as an integrated healthcare company.
  2. FY2020RestatedAnnual report

    「Based on the principle that “building health builds happiness,” our group, as an integrated healthcare company, engages in the research and development, manufacture, and sale of pharmaceuticals that address international medical needs and consumer healthcare products focused on self-medication, in order to contribute to improving quality of life.」

    The company continues to pursue its basic policy of contributing to improved quality of life as an integrated healthcare company.
  3. FY2019RestatedAnnual report

    「Based on the principle that “building health builds happiness,” our group, as an integrated healthcare company, engages in the research and development, manufacture, and sale of pharmaceuticals that address international medical needs and consumer healthcare products focused on self-medication, in order to contribute to improving quality of life.」

    The company continues to pursue its basic policy of contributing to improved quality of life as an integrated healthcare company.
  4. FY2017First statedAnnual report

    「Based on the principle that “building health builds happiness,” our group, as an integrated healthcare company, engages in the research and development, manufacture, and sale of pharmaceuticals that address international medical needs and consumer healthcare products focused on self-medication, in order to contribute to improving quality of life.」

    The company describes its basic corporate philosophy and its efforts to improve quality of life through prescription pharmaceuticals and consumer healthcare products as its basic policy.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Zeria Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.